|
|
|
11/8/2021
|
|
When:
|
11/8/2021
2:00 PM
|
|
Where:
|
United States
|
Online registration is closed.
|
|
« Go to Upcoming Event List
|
|
|
Learning Objectives: - Describe the current management of metastatic colorectal, gastric, and gastroesophageal junction (GEJ) cancers using clinical case scenarios in these diseases
- Identify approved indication, dosing, monitoring, and important safety information for LONSURF®, an oral chemotherapy agent
- Review critical data for LONSURF® in treating metastatic colorectal, gastric, and gastroesophageal junction(GEJ)cancers, including clinical trial design, efficacy, and safety outcomes
|
|
|
Print Page
